EOF Conference: “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps”
HACRO participated in the scientific conference organized by the National Organization for Medicines (EOF) on Wednesday, February 4, 2026, titled “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps.”
The President, Ms. Evangelia Koraki, in her presentation entitled “The pivotal role of EOF in the progress of clinical research in Greece” highlighted the multiple benefits of clinical trials for patients and the country, and emphasized the central role of EOF in protecting patients’ rights and safety, ensuring data reliability as well as enhancing Greece’s attractiveness as a destination for conducting clinical trials.
The presentation is available in the video below:
More news
View all →
“Why Europe?”: Lia Koraki on Europe’s Strengths in Clinical Research
As part of the “Why Europe?” campaign by the European CRO Federation (EUCROF), Evangelia (Lia) Koraki, President of HACRO – Hellenic Association of CROs…
Read more
HACRO Joins the 18th Greece Race for the Cure® in Support of Breast Cancer Awareness
For yet another year, HACRO - Hellenic Association of CROs proudly participated in the 18th Greece Race for the Cure®, held on Sunday, October…
Read more
HACRO President Evangelia (Lia) Koraki Speaks at the EUPATI Greece Patient Academy
Patient information and education are essential prerequisites for their meaningful participation in clinical research. As part of the three-day educational programme of the EUPATI…
Read more
